PCSK9 and paraneoplastic neurologic syndrome: This evidence suggests that HDL-C may upregulate the proportion of PCSK9 monomers in plasma, and reduce its ability to degrade LDL-R, which is conducive to reducing blood lipid levels in PNS patients.